Rodrigo Lázaro‐Gorines

A novel Carcinoembryonic Antigen (CEA)-Targeted Trimeric Immunotoxin shows significantly enhanced Antitumor Activity in Human Colorectal Cancer Xenografts

Rodrigo Lázaro‐Gorines, Javier Ruiz‐de‐la‐Herrán, Rocío Navarro et al. · Scientific Reports · 2019 · 39 citations · Full text

A PD-L1/EGFR bispecific antibody combines immune checkpoint blockade and direct anti-cancer action for an enhanced anti-tumor response

Laura Rubio‐Pérez, Rodrigo Lázaro‐Gorines, Seandean L. Harwood et al. · OncoImmunology · 2023 · 15 citations · Full text

Inclusion of a Furin Cleavage Site Enhances Antitumor Efficacy against Colorectal Cancer Cells of Ribotoxin α-Sarcin- or RNase T1-Based Immunotoxins

Javier Ruiz‐de‐la‐Herrán, Jaime Tomé‐Amat, Rodrigo Lázaro‐Gorines et al. · Toxins · 2019 · 14 citations · Full text

Immunology, Peptide Science, Immunotherapeutics +24

Tumor targeted 4-1BB agonist antibody-albumin fusions with high affinity to FcRn induce anti-tumor immunity without toxicity

Oana Hangiu, Marta Compte, Anders Dinesen et al. · iScience · 2022 · 14 citations · Full text

A TIM-3–Fc decoy secreted by engineered T cells improves CD19 CAR T-cell therapy in B-cell acute lymphoblastic leukemia

Aïda Falgàs, Rodrigo Lázaro‐Gorines, Samanta Romina Zanetti et al. · Blood · 2025 · 12 citations · Full text